Skip to content
52
PricingSign in

Connections

Amgen

460 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Amgen

Federal lobbying records

Open page
Amgen: all 251 bills it lobbied on and all 208 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.Includes 40 other records under the same name, such as its political action committee and state lobbying filings.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of Amgen
HR 1Bills it lobbied onAmgen named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 17 lobbying reports.17 reports
HR 1492Bills it lobbied onAmgen named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 13 lobbying reports.13 reports
S 1040Bills it lobbied onAmgen named S 1040, “Drug Competition Enhancement Act”, in 10 lobbying reports.10 reports
S 1041Bills it lobbied onAmgen named S 1041, “Affordable Prescriptions for Patients Act”, in 10 lobbying reports.10 reports
HR 1672Bills it lobbied onAmgen named HR 1672, “Maintaining Investments in New Innovation Act”, in 10 lobbying reports.10 reports
HR 946Bills it lobbied onAmgen named HR 946, “ORPHAN Cures Act”, in 10 lobbying reports.10 reports
HR 1968Bills it lobbied onAmgen named HR 1968, “Full-Year Continuing Appropriations and Extensions Act, 2025”, in 9 lobbying reports.9 reports
HR 2214Bills it lobbied onAmgen named HR 2214, “DRUG Act”, in 8 lobbying reports.8 reports
AB 36Bills it lobbied onAmgen named AB 36, “Confidentiality of writings”, in 7 lobbying reports.7 reports
HR 5526Bills it lobbied onAmgen named HR 5526, “Biosimilar Red Tape Elimination Act”, in 7 lobbying reports.7 reports
HR 1574Bills it lobbied onAmgen named HR 1574, “RESTORE Patent Rights Act of 2025”, in 6 lobbying reports.6 reports
HR 5256Bills it lobbied onAmgen named HR 5256, “340B ACCESS Act”, in 6 lobbying reports.6 reports
AB 1460Bills it lobbied onAmgen named AB 1460, “Prescription drug pricing”, in 6 lobbying reports.6 reports
HR 3152Bills it lobbied onAmgen named HR 3152, “Patent Eligibility Restoration Act of 2025”, in 6 lobbying reports.6 reports
S 1553Bills it lobbied onAmgen named S 1553, “PREVAIL Act”, in 6 lobbying reports.6 reports
HR 3160Bills it lobbied onAmgen named HR 3160, “PREVAIL Act”, in 6 lobbying reports.6 reports
S 1546Bills it lobbied onAmgen named S 1546, “Patent Eligibility Restoration Act of 2025”, in 6 lobbying reports.6 reports
AB 1277Bills it lobbied onAmgen named AB 1277, “Sherman Food, Drug, and Cosmetic Law”, in 6 lobbying reports.6 reports
SB 790Bills it lobbied onAmgen named SB 790, “Dreissenid mussel infestation prevention: grants”, in 6 lobbying reports.6 reports
HR 3517Bills it lobbied onAmgen named HR 3517, “Social Security Enhancement and Protection Act of 2025”, in 5 lobbying reports.5 reports
SB 419Bills it lobbied onAmgen named SB 419, “Solid waste: home-generated sharps”, in 5 lobbying reports.5 reports
HR 6166Bills it lobbied onAmgen named HR 6166, “Lowering Drug Costs for American Families Act”, in 4 lobbying reports.4 reports
S 2296Bills it lobbied onAmgen named S 2296, “National Defense Authorization Act for Fiscal Year 2026”, in 4 lobbying reports.4 reports
SB 598Bills it lobbied onAmgen named SB 598, “Biosimilars”, in 4 lobbying reports.4 reports
AB 558Bills it lobbied onAmgen named AB 558, “Chemical substances: testing”, in 4 lobbying reports.4 reports
S 3019Bills it lobbied onAmgen named S 3019, “No Big Blockbuster Bailouts Act”, in 4 lobbying reports.4 reports
AB 103Bills it lobbied onAmgen named AB 103, “Pharmaceuticals: marketing activities”, in 4 lobbying reports.4 reports
AB 809Bills it lobbied onAmgen named AB 809, “Bank and corporation taxes: apportionment: business income”, in 4 lobbying reports.4 reports
S 3345Bills it lobbied onAmgen named S 3345, “PBM Price Transparency and Accountability Act”, in 4 lobbying reports.4 reports
SB 17Bills it lobbied onAmgen named SB 17, “Health care: prescription drug costs”, in 4 lobbying reports.4 reports
SB 671Bills it lobbied onAmgen named SB 671, “Pharmacy: biological product”, in 4 lobbying reports.4 reports
SB 727Bills it lobbied onAmgen named SB 727, “Medical waste: pharmaceutical product stewardship program”, in 4 lobbying reports.4 reports
HR 6485Bills it lobbied onAmgen named HR 6485, “Skinny Labels, Big Savings Act”, in 4 lobbying reports.4 reports
AB 45Bills it lobbied onAmgen named AB 45, “Household hazardous waste”, in 4 lobbying reports.4 reports
SB 41Bills it lobbied onAmgen named SB 41, “Pharmacy benefits”, in 4 lobbying reports.4 reports
HR 5509Bills it lobbied onAmgen named HR 5509, “Safe Step Act”, in 4 lobbying reports.4 reports
AB 444Bills it lobbied onAmgen named AB 444, “Medical waste: home-generated medical waste”, in 4 lobbying reports.4 reports
AB 934Bills it lobbied onAmgen named AB 934, “Property taxes: refund proceedings: local assessments”, in 4 lobbying reports.4 reports
HR 3269Bills it lobbied onAmgen named HR 3269, “ETHIC Act”, in 4 lobbying reports.4 reports
HR 4581Bills it lobbied onAmgen named HR 4581, “340B PATIENTS Act of 2025”, in 4 lobbying reports.4 reports
AB 501Bills it lobbied onAmgen named AB 501, “Pharmaceutical devices”, in 4 lobbying reports.4 reports
HR 4317Bills it lobbied onAmgen named HR 4317, “PBM Reform Act of 2025”, in 4 lobbying reports.4 reports
SB 866Bills it lobbied onAmgen named SB 866, “Health care coverage: prescription drugs”, in 4 lobbying reports.4 reports
SB 486Bills it lobbied onAmgen named SB 486, “Medical waste: sharps waste”, in 4 lobbying reports.4 reports
AB 824Bills it lobbied onAmgen named AB 824, “Business: preserving access to affordable drugs”, in 4 lobbying reports.4 reports
HR 1328Bills it lobbied onAmgen named HR 1328, “Supply Chain Security and Growth Act of 2025”, in 4 lobbying reports.4 reports
SB 212Bills it lobbied onAmgen named SB 212, “Solid waste: pharmaceutical and sharps waste stewardship”, in 3 lobbying reports.3 reports
SB 966Bills it lobbied onAmgen named SB 966, “Pharmacy benefits”, in 3 lobbying reports.3 reports
AB 2560Bills it lobbied onAmgen named AB 2560, “Bank and corporation taxes: apportionment: business income”, in 3 lobbying reports.3 reports
AB 463Bills it lobbied onAmgen named AB 463, “Pharmaceutical Cost Transparency Act of 2016”, in 3 lobbying reports.3 reports
Showing 50 of 460

In the news

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…